IP Library Granted Patent US 7,655,791
Granted Patent B2
US 7,655,791 · App. 10/293,048 · Granted Feb 2, 2010

DNA amplification and sequencing using DNA molecules generated by random fragmentation

Assignee: Rubicon Genomics, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,655,791
App. No.
10/293,048
Filed
Nov 13, 2002
Granted
Feb 2, 2010
Kind
B2
Art Unit
1637
USPC
435/6
Abstract

The present invention is directed to methods to prepare a DNA molecule or a plurality of DNA molecules by random fragmentation. In some embodiments, the present invention regards preparing a template for DNA sequencing by random fragmentation. In specific embodiments, the random fragmentation comprises chemical fragmentation, mechanical fragmentation, or enzymatic fragmentation. In further specific embodiments, a universal sequence is attached to the 3′ end of the DNA fragments, such as by ligation of an adaptor sequence or by homopolymeric tailing with terminal deoxynucleotidyltransferase. In other embodiments, a library is prepared with methods of the present invention.

Claims (46)

1. A method of preparing a DNA molecule, comprising:

obtaining a DNA molecule;

fragmenting the DNA molecule by thermal or chemical fragmentation to produce DNA fragments, wherein the ends of at least some of the DNA fragments comprise an enzymatically non-extendable 3′ end;

repairing non-extendable 3′ ends on DNA fragments having non-extendable 3′ ends and generating a guanine homopolymer extension on 3′ ends of the DNA fragments using terminal deoxynucleotidyltransferase in the presence of a guanine ribonucleotide, guanine deoxyribonucleotide, or both.

2. The method of claim 1 , further comprising concomitantly sequencing a plurality of the fragments.

3. The method of claim 1 , wherein said fragmentation is by acid catalytic hydrolysis, alkaline catalytic hydrolysis, hydrolysis by metal ions, hydroxyl radicals, irradiation, or heating.

4. The method of claim 1 , wherein said fragmentation is by heating.

5. The method of claim 4 , wherein said heating is to a temperature of between about 40° C. and 120° C.

6. The method of claim 4 , wherein said heating is to a temperature of between about 80° C. and 100° C.

7. The method of claim 4 , wherein said heating is to a temperature of between about 90° C. and 100° C.

8. The method of claim 4 , wherein said heating is to a temperature of between about 92° C. and 98° C.

9. The method of claim 4 , said heating is to a temperature of between about 93° C. and 97° C.

10. The method of claim 4 , wherein said heating is to a temperature of between about 94° C. and 96° C.

11. The method of claim 4 , wherein said heating is to a temperature of about 95° C.

12. The method of claim 4 , wherein said heating of the DNA molecule is in a solution having from 0 to about 100 mM concentration of a salt.

13. The method of claim 4 , wherein said heating is in a solution having from about 0 to about 10 mM concentration of salt.

14. The method of claim 4 , wherein said heating is in a solution having from about 0.1 to about 1 mM concentration of salt.

15. The method of claim 4 , wherein said heating is in a solution having from about 0.1 to about 0.5 mM concentration of salt.

16. The method of claim 4 , wherein said heating is in a solution of 10 mM Tris, pH 8.0; 1 mM EDTA.

17. The method of claim 4 , wherein said heating is in a solution of water.

18. The method of claim 1 , further comprising preparing a library of DNA molecules.

19. The method of claim 18 , further comprising concomitantly sequencing a plurality of the fragments.

20. The method of claim 1 , further comprising amplifying a plurality of the fragments.

21. The method of claim 20 , wherein the amplification utilizes:

a second primer complementary to a known sequence in the DNA fragments; and

a third primer complementary to the first primer.

22. The method of claim 21 , further comprising the step of sequencing concomitantly said plurality of DNA fragments using a fourth primer complementary to said known sequence in the DNA fragments.

23. The method of claim 22 , wherein said fourth primer is said second primer.

24. The method of claim 21 , further comprising

sequencing said plurality of DNA fragments using a fourth primer complementary to said known sequence in the DNA fragments.

25. The method of claim 24 , wherein said fourth primer is said second primer.

26. The method of claim 1 , further comprising:

concomitantly sequencing a first region in said plurality of DNA molecules using a primer complementary to a known sequence in said plurality of DNA molecules; and

concomitantly sequencing a second region in said plurality of DNA molecules using a primer complementary to sequence determined from the sequencing of the first region,

wherein the next consecutive sequencing of a region in the overlapping series of nucleic acid sequences is produced by initiating sequencing from the sequence obtained in a preceding overlapping sequencing product.

27. The method of claim 1 , wherein the plurality of DNA fragments comprises DNA fragments having part or all of the sequences which generate the secondary structure.

28. The method of claim 27 , further comprising concomitantly sequencing the plurality of primer-linked fragments.

29. The method of claim 27 , wherein said plurality of DNA fragments further comprises DNA fragments having none of the sequences which generate the secondary structure.

30. The method of claim 27 , wherein said secondary structure is a hairpin, a G quartet, or a triple helix.

31. The method of claim 1 , wherein the obtained DNA molecule comprises genomic DNA, BAC DNA, or plasmid DNA.

32. The method of claim 1 , further defined as comprising

attaching a labeled primer having substantially known sequence to at least one end of a plurality of the DNA fragments to produce labeled primer-linked fragments.

33. The method of claim 32 , wherein said attaching step of a labeled primer comprises ligation of an adaptor molecule to at least one end of the DNA fragment, wherein the adaptor molecule comprises the label.

34. The method of claim 32 , wherein the label comprises a radionuclide, an affinity tag, a hapten, an enzyme, a chromophore, or a fluorophore.

35. The method of claim 1 , wherein the guanine ribonucleotide, guanine deoxyribonucleotide, or both, are labeled and/or wherein the attaching further comprises other deoxyribonucleotides or ribonucleotides that are labeled.

36. The method of claim 35 , wherein the label comprises a radionuclide, an affinity tag, a hapten, an enzyme, a chromophore, or a fluorophore.

Assignments (2)
MERGER Recorded Sep 19, 2017
From: RUBICON GENOMICS, INC.
To: TAKARA BIO USA, INC.
Reel/Frame 043631/0549 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 28, 2003
From: MAKAROV, VLADIMIR L.; SLEPTSOVA, IRINA; KAMBEROV, EMMANUEL; BRUENING, ERIC
To: RUBICON GENOMICS, INC.
Reel/Frame 013799/0497 →
Continuity (2)
Provisional Application 6033822400 · Nov 13, 2001
Related Publication 20030143599A1 · Jul 31, 2003